LH

Laboratory
D

LH

Arincen56/100B

Laboratory company profile

CEO
Adam H. Schechter
Employees
71,000
Headquarters
358 South Main Street, Burlington, NC 27215, US
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO date
29 Mar 1990
Stock exchange
NYSE
ISIN
US5049221055

Website:labcorp.com

About the company

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Employees

Laboratory had about 71,000 employees at the end of fiscal year 2025 (31 December 2025), by its annual report. That is 1.4% more than a year before.

Employees Change on the year
Fiscal yearEmployeesChange on the yearRevenue per employeeNet income per employee
FY202571,000+1.43%196.50K USD12.35K USD
FY202470,000+4.48%185.84K USD10.66K USD
FY202367,000-16.25%181.52K USD6.24K USD
FY202280,000+5.96%148.30K USD15.99K USD
FY202175,500+4.28%173.99K USD31.49K USD
FY202072,400+11.38%193.07K USD21.49K USD
FY201965,000+6.56%177.77K USD12.67K USD
FY201861,000+1.67%185.79K USD14.49K USD
FY201760,000+15.38%174.02K USD21.14K USD
FY201652,000+4.00%185.42K USD14.08K USD
FY201550,000+38.89%173.60K USD8.74K USD
FY201436,000+5.88%166.99K USD14.20K USD
FY201334,0000.00%170.83K USD16.88K USD
FY201234,000+9.68%166.81K USD17.15K USD
FY201131,0000.00%178.78K USD16.76K USD
FY201031,000+10.71%161.42K USD18.01K USD
FY200928,0000.00%167.67K USD19.40K USD
FY200928,000+7.69%——
FY200826,000+4.00%——
FY200625,000+4.17%143.63K USD17.26K USD
FY200624,000+2.13%——
FY200523,500+2.17%——
FY200423,000-4.17%——
FY200224,000+22.45%104.49K USD10.61K USD
FY200119,600+3.98%112.23K USD9.16K USD
FY200018,850+4.96%101.82K USD5.95K USD
FY199917,960-4.47%94.58K USD3.64K USD
FY199818,800+1.08%85.78K USD3.66K USD
FY199718,600-15.45%81.67K USD-5.75K USD
FY199622,000-10.57%73.08K USD-6.98K USD
FY199524,600+75.71%58.21K USD-500.00 USD
FY199414,000—62.32K USD2.15K USD

Employees at each fiscal year end, as the company reports them in its annual report (10-K); revenue and net income per employee are the fiscal year's over that count.

Who owns Laboratory

Institutions such as funds, banks and insurers held 97.2% of Laboratory's shares on 30 June 2026, 1,071 of them reporting holdings to the SEC; the rest is held by individual investors and other shareholders.

Institutions 97.2%Other shareholders 2.8%

Shares free to trade

Free float 80.82M shares ·99.5% Closely held 381.64K shares ·0.5%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

Common questions about Laboratory

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.